NCT04616092View on ClinicalTrials.gov

Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery

PHASE4UnknownINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

April 30, 2023

Conditions
Cerebral Aneurysm UnrupturedIron Deficiency AnemiaSurgery
Interventions
DRUG

FEFINJECT

FEFINJECT injection

Sponsors

Collaborators (1)

Vifor Pharma
All Listed Sponsors
collaborator

Vifor Pharma

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT04616092 - Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery | Biotech Hunter | Biotech Hunter